CN Stock MarketDetailed Quotes
300147 Xiangxue Pharmaceutical
- 12.29
- +0.49+4.15%
Market Closed Nov 19 15:00 CST
8.13BMarket Cap-17632P/E (TTM)
12.35High11.64Low447.39KlotVolume11.95Open11.80Pre Close534.04MTurnover6.81%Turnover RatioLossP/E (Static)661.28MShares16.4952wk High4.76P/B8.08BFloat Cap3.0052wk Low14.16Limit Up657.46MShs Float41.78Historical High9.44Limit Down6.02%Amplitude3.00Historical Low--Dividend TTM11.94Avg Price193.87KlotAsk--Div YieldTTM100Lot Size239.39KlotBid
Xiangxue Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -11.07%1.35B | -8.95%931.75M | -5.33%487.34M | -11.50%2B | -14.18%1.52B | -15.81%1.02B | -5.93%514.77M | -22.18%2.26B | -22.35%1.77B | -21.00%1.22B |
| Refunds of taxes and levies | -50.85%13.13M | -63.62%7.34M | 36.32%4.41M | 8.07%32.82M | -1.46%26.71M | 7.29%20.17M | 14.32%3.24M | 83.10%30.37M | 119.29%27.1M | 95.53%18.8M |
| Cash received relating to other operating activities | -36.09%27.13M | -62.55%15.3M | -69.76%10.15M | -56.21%82.97M | -77.12%42.45M | -76.95%40.85M | -77.74%33.55M | -2.89%189.46M | 92.40%185.5M | 204.88%177.18M |
| Cash inflows from operating activities | -12.41%1.39B | -11.98%954.39M | -9.00%501.9M | -14.68%2.11B | -19.91%1.59B | -23.18%1.08B | -21.29%551.56M | -20.41%2.48B | -16.98%1.98B | -12.13%1.41B |
| Goods services cash paid | 4.96%904.12M | 2.81%583.97M | -4.14%281.59M | -24.27%1.16B | -32.40%861.36M | -40.10%567.99M | -36.32%293.74M | -18.28%1.53B | -17.66%1.27B | -0.80%948.19M |
| Staff behalf paid | -0.69%265.84M | 3.58%186.05M | 8.77%101.12M | 12.94%357.88M | 3.41%267.69M | 0.05%179.62M | 13.02%92.97M | -8.35%316.89M | 2.44%258.87M | 6.17%179.53M |
| All taxes paid | 29.02%97.32M | 26.78%70.78M | 19.44%37.22M | 8.93%104.95M | 6.45%75.43M | 22.28%55.83M | 42.04%31.16M | -27.43%96.35M | -33.80%70.86M | -42.49%45.66M |
| Cash paid relating to other operating activities | -16.59%157.36M | -6.35%120.21M | -28.65%56.16M | -25.47%230.07M | -27.73%188.67M | -28.86%128.36M | -47.62%78.71M | -39.12%308.71M | -15.31%261.07M | -35.77%180.44M |
| Cash outflows from operating activities | 2.26%1.42B | 3.14%961.02M | -4.13%476.09M | -17.77%1.85B | -25.30%1.39B | -31.17%931.79M | -30.62%496.58M | -21.21%2.25B | -15.82%1.87B | -8.85%1.35B |
| Net cash flows from operating activities | -118.84%-36.16M | -104.35%-6.64M | -53.05%25.81M | 15.86%263.44M | 68.33%191.97M | 164.45%152.55M | 467.27%54.98M | -11.61%227.38M | -32.26%114.05M | -52.34%57.68M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --23.41M | --14.2M | ---- | -96.70%1.91M | ---- | --0 | ---- | 374.15%57.91M | 403.20%57.72M | -80.87%2.19M |
| Cash received from returns on investments | ---- | ---- | ---- | -19.43%483.35K | -95.14%15.71K | ---- | ---- | 54.39%599.88K | -16.71%323.6K | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --30.08M | --21.07M | --287.4K | --0 | ---- | --0 | --0 | 4,375.46%7.71M | 59,157.69%7.7M | --6.47M |
| Net cash received from disposal of subsidiaries and other business units | 4,420.33%16.35M | ---- | ---- | -99.92%361.77K | -99.92%361.77K | ---- | ---- | 634.21%435.74M | --435.74M | --89.9M |
| Cash received relating to other investing activities | --13.04M | 133,750.98%13.04M | --9.03M | -97.24%10.97M | ---- | -100.00%9.74K | --0 | -59.31%397.1M | 32.38%396.07M | 35.33%276.07M |
| Cash inflows from investing activities | 21,854.12%82.87M | 495,781.72%48.3M | --9.31M | -98.47%13.73M | -99.96%377.49K | -100.00%9.74K | --0 | -14.21%899.06M | 188.54%897.56M | 73.57%374.63M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -32.49%27.73M | -28.62%23.44M | -13.60%17.58M | -84.74%56.03M | -72.33%41.07M | -67.82%32.84M | -55.97%20.34M | -27.25%367.27M | -68.97%148.4M | -72.75%102.06M |
| Cash paid to acquire investments | ---- | ---- | ---- | --400K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | --27.2M | --27.2M | --13M | -92.82%10.95M | ---- | --0 | --0 | -57.35%152.53M | 951.33%535.46M | 2,152.58%90.1M |
| Cash outflows from investing activities | 33.74%54.92M | 54.19%50.64M | 50.30%30.58M | -87.04%67.38M | -93.99%41.07M | -82.91%32.84M | -55.97%20.34M | -52.87%519.8M | 11.13%683.86M | -54.74%192.16M |
| Net cash flows from investing activities | 168.69%27.95M | 92.90%-2.33M | -4.52%-21.26M | -114.15%-53.66M | -119.04%-40.69M | -117.99%-32.83M | -107.19%-20.34M | 791.21%379.26M | 170.22%213.7M | 187.40%182.47M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --420K | --420K | --420K | -98.82%530K | ---- | --0 | --0 | -69.37%45.06M | -69.37%45.06M | -59.77%45.06M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --420K | --420K | --420K | --530K | ---- | ---- | --0 | ---- | -69.41%45M | -59.77%45.06M |
| Cash from borrowing | -70.20%12.8M | -70.20%12.8M | -70.20%12.8M | -77.63%126.15M | -91.96%42.95M | -91.14%42.95M | -87.67%42.95M | -78.42%563.91M | -74.90%533.91M | -68.96%484.91M |
| Cash received relating to other financing activities | -62.16%25.28M | -45.65%24.62M | -85.41%4.42M | -54.80%265.33M | -83.98%66.8M | -79.69%45.3M | -85.07%30.3M | -70.63%587M | -68.01%417M | -68.37%223M |
| Cash inflows from financing activities | -64.92%38.5M | -57.12%37.84M | -75.92%17.64M | -67.22%392.01M | -88.98%109.75M | -88.28%88.25M | -86.72%73.25M | -74.87%1.2B | -72.16%995.97M | -68.35%752.97M |
| Borrowing repayment | -76.84%19.49M | -81.41%12.79M | -63.54%10.37M | -82.39%186.06M | -90.32%84.17M | -90.52%68.79M | -93.11%28.44M | -67.93%1.06B | -69.98%869.96M | -64.33%725.29M |
| Dividend interest payment | -56.82%55.38M | -41.07%53.52M | -13.03%38.49M | -10.91%156.62M | -10.75%128.26M | 1.27%90.83M | -14.74%44.26M | -18.95%175.8M | 9.56%143.71M | -1.43%89.69M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | 87.50%15M | --15.97M | ---- | ---- | --8M | ---- | ---- | ---- |
| Cash payments relating to other financing activities | -73.09%24.9M | -87.62%11.09M | -92.72%5.51M | -59.43%249.96M | -72.67%92.53M | -42.12%89.53M | -61.68%75.73M | -64.89%616.12M | -54.57%338.59M | -64.30%154.69M |
| Cash outflows from financing activities | -67.28%99.77M | -68.93%77.4M | -63.37%54.38M | -67.94%592.64M | -77.45%304.97M | -74.31%249.15M | -77.60%148.43M | -64.90%1.85B | -64.17%1.35B | -62.09%969.67M |
| Net cash flows from financing activities | 68.61%-61.28M | 75.41%-39.56M | 51.14%-36.74M | 69.27%-200.63M | 45.21%-195.22M | 25.75%-160.9M | 32.34%-75.18M | -28.54%-652.77M | -81.02%-356.29M | -21.47%-216.71M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -126.72%-426.86 | -75.62%843.58 | 100.08%46.22 | -100.40%-3.6K | -99.53%1.6K | -94.46%3.46K | -226.24%-54.63K | 1,078.06%901.05K | 87.37%336.8K | 237.12%62.48K |
| Net increase in cash and cash equivalents | -58.16%-69.49M | -17.85%-48.53M | 20.73%-32.19M | 120.23%9.15M | -55.74%-43.94M | -275.15%-41.17M | -125.90%-40.6M | 85.20%-45.23M | 91.52%-28.21M | 108.83%23.51M |
| Add:Begin period cash and cash equivalents | 7.00%135.22M | 7.00%135.22M | 7.00%135.22M | -26.36%126.38M | -26.36%126.38M | -26.36%126.38M | -26.36%126.38M | -64.04%171.61M | -64.04%171.61M | -64.04%171.61M |
| End period cash equivalent | -20.26%65.73M | 1.76%86.7M | 20.13%103.04M | 7.24%135.53M | -42.51%82.44M | -56.33%85.2M | -73.88%85.77M | -26.36%126.38M | -0.81%143.4M | -7.52%195.12M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Reservations with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Beijing Dahua International Accounting Firm (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data